Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Sofosbuvir/velpatasvir/voxilaprevir for Patients with Chronic Hepatitis C Virus Infection Previously Treated with NS5A Direct-Acting Antivirals: a Real-World Multicenter Cohort in Taiwan

Chen-Hua Liu,Cheng-Yuan Peng,Chun-Jen Liu,Chi-Yi Chen,Ching-Chu Lo,Kuo-Chih Tseng,Pei-Yuan Su,Wei-Yu Kao,Ming-Chang Tsai,Hung-Da Tung,Hao-Tsai Cheng,Fu-Jen Lee,Chia-Sheng Huang,Ke-Jhang Huang,Yu-Lueng Shih,Sheng-Shun Yang,Jo-Hsuan Wu,Hsueh-Chou Lai,Yu-Jen Fang,Po-Yueh Chen,Jow-Jyh Hwang,Chi-Wei Tseng,Wei-Wen Su,Chun-Chao Chang,Pei-Lun Lee,Jyh-Jou Chen,Chi-Yang Chang,Tsai-Yuan Hsieh,Chung-Hsin Chang,Yi-Jie Huang,Jia-Horng Kao

Hepatology international（2023）

Cited 0|Views8
No score
Key words
Hepatitis C virus,Direct-acting antiviral,Sofosbuvir,Velpatasvir,Voxilaprevir,Resistance-associated substitution,Pangenotypic,Sustained virologic response,Effectiveness,Safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined